NZ209514A - Pharmaceutical compositions containing erythro-3,4-dihydroxyphenylserine and a decarboxylase inhibitor - Google Patents

Pharmaceutical compositions containing erythro-3,4-dihydroxyphenylserine and a decarboxylase inhibitor

Info

Publication number
NZ209514A
NZ209514A NZ20951484A NZ20951484A NZ209514A NZ 209514 A NZ209514 A NZ 209514A NZ 20951484 A NZ20951484 A NZ 20951484A NZ 20951484 A NZ20951484 A NZ 20951484A NZ 209514 A NZ209514 A NZ 209514A
Authority
NZ
New Zealand
Prior art keywords
erythro
dops
dihydroxyphenylserine
treatment
decarboxylase inhibitor
Prior art date
Application number
NZ20951484A
Other languages
English (en)
Inventor
Mori Tadashi
Nakajima Teruo
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58175581A external-priority patent/JPS6067420A/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of NZ209514A publication Critical patent/NZ209514A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ20951484A 1983-09-22 1984-09-12 Pharmaceutical compositions containing erythro-3,4-dihydroxyphenylserine and a decarboxylase inhibitor NZ209514A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58175581A JPS6067420A (ja) 1983-09-22 1983-09-22 精神運動興奮抑制剤
CA000452844A CA1225598A (en) 1983-09-22 1984-04-26 Pharmaceutical composition and method for treatment of psychomotor excitement

Publications (1)

Publication Number Publication Date
NZ209514A true NZ209514A (en) 1988-03-30

Family

ID=25670371

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ20951484A NZ209514A (en) 1983-09-22 1984-09-12 Pharmaceutical compositions containing erythro-3,4-dihydroxyphenylserine and a decarboxylase inhibitor

Country Status (10)

Country Link
BE (1) BE900654A (de)
CH (1) CH664493A5 (de)
DE (1) DE3433675A1 (de)
FR (1) FR2552327B1 (de)
GB (1) GB2146899B (de)
IT (1) IT1175863B (de)
MX (1) MX167915B (de)
NL (1) NL8402850A (de)
NZ (1) NZ209514A (de)
SE (1) SE468882B (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580059A5 (de) * 1973-08-22 1976-09-30 Hoffmann La Roche
US3920728A (en) * 1973-08-22 1975-11-18 Hoffmann La Roche Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine
NL7700945A (nl) * 1976-02-13 1977-08-16 Merck & Co Inc Werkwijze voor het bereiden van bloeddruk- verhogende preparaten.
JPS52125630A (en) * 1976-04-14 1977-10-21 Kyowa Hakko Kogyo Co Ltd Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS56104815A (en) * 1980-01-23 1981-08-20 Sumitomo Chem Co Ltd Remedy for peripheral orthostatic hypotension
JPS5852219A (ja) * 1981-09-22 1983-03-28 Sumitomo Chem Co Ltd パ−キンソン病治療剤

Also Published As

Publication number Publication date
GB2146899B (en) 1987-11-25
CH664493A5 (de) 1988-03-15
SE8404715L (sv) 1985-03-23
SE8404715D0 (sv) 1984-09-20
BE900654A (fr) 1985-03-21
IT1175863B (it) 1987-07-15
FR2552327A1 (fr) 1985-03-29
NL8402850A (nl) 1985-04-16
FR2552327B1 (fr) 1988-01-15
SE468882B (sv) 1993-04-05
GB2146899A (en) 1985-05-01
DE3433675A1 (de) 1985-04-11
GB8423725D0 (en) 1984-10-24
MX167915B (es) 1993-04-22

Similar Documents

Publication Publication Date Title
US6306910B1 (en) Use of Gaba-analogues for treating insomnia
RU2244558C2 (ru) Анестетическая композиция, включающая антагонист nmda и альфа-2 адренергический агонист
US4529603A (en) Pharmaceutical composition and method for treatment of psychomotor excitement
UA70315C2 (en) Pharmaceutical composition comprising metformin anpharmaceutical composition comprising metformin and fibrate useful for formulations intended for lowd fibrate useful for formulations intended for lowering hyperglycemia ering hyperglycemia
EP2129369A1 (de) Behandlung von adhd
Chase et al. Parkinson's disease: Modification by 5‐hydroxytryptophan
BRPI0618918B1 (pt) uso de um primeiro composto e um segundo composto para tratar uma condição de glicose sanguínea
WO2003092682A1 (en) Zonisamide use in obesity and eating disorders
US8293211B2 (en) CB1 receptor antagonists and uses thereof
Playfer Parkinson's disease
JPH03209335A (ja) 慢性神経変質性疾病予防薬の製法及び作用量のｎｍｄａ―受容体複合体の拮抗剤を含有する薬剤
Shuaib et al. Neuroprotection with felbamate: a 7-and 28-day study in transient forebrain ischemia in gerbils
JPH0227327B2 (de)
Rose et al. Studies on isoxsuprine hydrochloride for the treatment of navicular disease
EP0176309A2 (de) Verwendung von N-(2-Aminocyclohexyl)benzolessigsäureamiden in der Behandlung von Ischämie des Gehirns
KR930007252B1 (ko) 우울증 치료용 약학조성물
US20020147206A1 (en) Combination treatment of multiple sclerosis (MS), other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy
NZ209514A (en) Pharmaceutical compositions containing erythro-3,4-dihydroxyphenylserine and a decarboxylase inhibitor
EP1084704B1 (de) Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie
US6680343B1 (en) Treatment of renal colic with GABA analogs
WO1994002144A1 (en) Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris
AU763273B2 (en) Analgesic regimen
US6992109B1 (en) Method for the treatment of incontinence
MXPA06014907A (es) Uso de acetil l-carnitina para preparacion de medicina para tratamiento de dolor neuropatico en pacientes diabeticos.
US6248786B1 (en) Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia